PubRank

Valérie Gausson

Author PubWeight™ 14.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antiviral immunity in Drosophila requires systemic RNA interference spread. Nature 2009 2.15
2 AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int 2003 1.91
3 Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 2002 1.58
4 RNAi-mediated immunity provides strong protection against the negative-strand RNA vesicular stomatitis virus in Drosophila. Proc Natl Acad Sci U S A 2010 1.34
5 RNA-mediated interference and reverse transcription control the persistence of RNA viruses in the insect model Drosophila. Nat Immunol 2013 1.24
6 Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis 2005 1.15
7 Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 2004 1.10
8 Respective role of uraemic toxins and myeloperoxidase in the uraemic state. Nephrol Dial Transplant 2006 1.01
9 Are advanced oxidation protein products potential uremic toxins? Kidney Int Suppl 2003 0.98
10 Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers. Kidney Int 2004 0.95
11 Proteinase-3 induces procaspase-3 activation in the absence of apoptosis: potential role of this compartmentalized activation of membrane-associated procaspase-3 in neutrophils. J Immunol 2005 0.85
12 Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease. Mediators Inflamm 2006 0.83
13 Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile. Blood Purif 2008 0.75